Summary The myLife CamAPS FX app, a hybrid closed-loop system for Type 1 diabetes management, is now available on iOS in the UK. This expansion increases access to automated insulin delivery technology, potentially improving the […]
Summary The Bukhman Foundation has pledged £100 million to revolutionize type 1 diabetes research and treatment, focusing on cell therapies and global collaboration. This historic gift aims to accelerate breakthroughs in new treatments and ultimately […]
Summary Medtronic is spinning off its diabetes business into a new independent company, while simultaneously grappling with a substantial tariff impact of up to $350 million. This move allows Medtronic to focus on high-growth markets […]
Summary This article discusses the groundbreaking discovery of Hybrid Insulin Peptides (HIPs) and their potential role in the development of type 1 diabetes. It explores how these peptides could serve as biomarkers for early diagnosis […]
Summary New research reveals low blood sugar levels contribute to diabetic retinopathy, potentially worsening vision loss. A protein, HIF, accumulates in retinal cells during hypoglycemia, disrupting the blood-retinal barrier. An experimental drug, 32-134D, shows promise […]
Summary This article discusses a recent study that investigated the effects of combining testosterone therapy with exercise for older women recovering from hip fractures. The study found that adding testosterone did not improve long-distance walking […]
Summary This article explores the future of diabetes treatment, examining recent advancements and the possibility of a cure. We delve into innovative technologies like artificial pancreases, cell therapies, and immunotherapies, while also discussing the role […]
Summary New research suggests that semaglutide, a popular drug for type 2 diabetes and weight loss, may also reduce the risk of Alzheimer’s disease. Studies have shown a significant link between the two diseases, and […]
Summary This article discusses recent advancements in diabetes technology, particularly focusing on Dexcom and Tandem Diabetes Care. Dexcom’s CEO highlighted the alignment of continuous glucose monitors (CGMs) with the current administration’s healthcare agenda, emphasizing their […]
Summary This article explores the latest advancements in managing childhood diabetes, focusing on technological breakthroughs like Continuous Glucose Monitors (CGMs) and insulin pumps, and emerging therapies. It also highlights the importance of lifestyle adjustments, family […]
© 2025 Newsguru LTD. All rights reserved.